LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of shareholders of BioScrip, Inc. (“BioScrip” or the “Company”) (NASDAQ:BIOS) concerning possible breaches of fiduciary duties by the Company or its fiduciaries. The investigation is focused on...
More...
